Biogen Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biogen stocks.

Biogen Stocks Recent News

Date Stock Title
May 1 ALNY Alnylam Pharmaceuticals Q1 2024 Earnings Preview
May 1 ALNY Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
Apr 30 BIIB Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
Apr 30 BIIB Biogen: Don't Overthink This One
Apr 30 ALNY Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
Apr 30 ALNY Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Apr 29 BIIB The Analyst Landscape: 27 Takes On Biogen
Apr 29 BIIB 10 Most Promising Stocks to Buy Before They Take Off
Apr 29 BIIB Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
Apr 29 BIIB Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Apr 28 BIIB Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Apr 27 BIIB Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 26 BIIB Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Apr 26 BIIB The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Apr 26 BIIB Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
Apr 25 BIIB Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
Apr 25 BIIB Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Apr 25 BIIB Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Apr 25 BIIB Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
Apr 25 BIIB For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
Biogen

Biogen Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.

Browse All Tags